CN Patent

CN111494399A — 用伊维菌素治疗红斑痤疮的炎性病灶

Assigned to Galderma SA · Expires 2020-08-07 · 6y expired

What this patent protects

描述了在个体中安全有效地治疗红斑痤疮炎性病灶的方法。所述方法涉及向受影响的皮肤区域一天一次外部施用组合物，所述组合物含有伊维菌素和药学上可接受的载体。已经证明，在减少炎性病灶数方面，用伊维菌素一天一次的外部治疗效果明显优于用甲硝哒唑一天两次的外部治疗效果。

USPTO Abstract

描述了在个体中安全有效地治疗红斑痤疮炎性病灶的方法。所述方法涉及向受影响的皮肤区域一天一次外部施用组合物，所述组合物含有伊维菌素和药学上可接受的载体。已经证明，在减少炎性病灶数方面，用伊维菌素一天一次的外部治疗效果明显优于用甲硝哒唑一天两次的外部治疗效果。

Drugs covered by this patent

Patent Metadata

Patent number
CN111494399A
Jurisdiction
CN
Classification
—
Expires
2020-08-07
Drug substance claim
No
Drug product claim
No
Assignee
Galderma SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.